Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
Analyst Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
AGM
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
Analyst Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
AGM
Access AGM Presentation
Wednesday
November
10
Time
10:00 AM
Kazia Therapeutics Annual General Meeting
Kazia Therapeutics (ASX:KZA, NASDAQ: KZIA). The Kazia team are distinguished by deep experience in drug development, empowered by a commitment to high-quality service, and inspired by a passion for making a difference in the lives of patients.
Annual Report
View Report
Notice of Meeting
View Notice
Proxy Document
View Document
Annual General Meeting Outline
Adoption of Remuneration Report;
Re-Election of Iain Ross;
Adoption of Employee Share Option Plan;
The grant of up to 1,000,000 FY20 Options to Dr James Garner;
The grant of up to 1,500,000 FY21 Options to Dr James Garner;
The ratification of prior issue of Placement Shares; and
Approval of Additional Placement capacity under Listing Rule 7.1A.
AGM Announcements
Read More
Email Alerts
For Investors
Contact Us
